C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2011
10/27/2011	US20110263512 Conjugates for the treatment of mesothelioma
10/27/2011	US20110263504 Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage
10/27/2011	US20110263501 Growth Hormone Conjugate with Increased Stability
10/27/2011	US20110263500 Curcumin Conjugates for Treating and Preventing Cancers
10/27/2011	US20110263499 Ifbm's to promote the specific attachment of target analytes to the surface of orthopedic implants
10/27/2011	US20110263488 Family of pesticidal proteins and methods for their use
10/27/2011	US20110263485 Bifunctional Griffithsin Analogs
10/27/2011	US20110263484 Single chain fc type iii interferons and methods of using same
10/27/2011	US20110263483 Compositions and methods for treating pathologic angiogenesis and vascular permeability
10/27/2011	US20110263482 Complement inhibitors
10/27/2011	US20110263451 Biological markers predictive of rheumatoid arthritis response to lymphotoxin antagonists
10/27/2011	US20110263450 Alzheimer's disease biomarkers
10/27/2011	US20110263435 Genetic markers for boar taint
10/27/2011	US20110263027 Adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby
10/27/2011	US20110263026 Construction of Protein-Responsive shRNA/RNAi Control System Using RNP Motif
10/27/2011	US20110263017 Technique for regulating regenration of tissue or faulty or abnormal part in organ using nell-1
10/27/2011	US20110263013 Compositions And Methods For Growing Embryonic Stem Cells
10/27/2011	US20110262994 Novel reagents and method for conjugating biological molecules
10/27/2011	US20110262968 Antibodies that bind to psca proteins for diagnosis of cancer
10/27/2011	US20110262964 Reagentless fluorescent biosensors comprising a designed ankyrin repeat protein module, rational design methods to create reagentless fluorescent biosensors and methods of their use
10/27/2011	US20110262963 Biosynthetically generated pyrroline-carboxy-lysine and site specific protein modifications via chemical derivatization of pyrroline-carboxy-lysine and pyrrolysine residues
10/27/2011	US20110262953 Phosphate Limited Inducible Promoter and A Bacillus Expression System
10/27/2011	US20110262944 Construction and crystallization of expression system for rna polymerase pb1-pb2 protein derived from influenza virus
10/27/2011	US20110262937 T1r hetero-oligomeric taste receptors and cell lines that express said receptors and use thereof for identification of taste compounds
10/27/2011	US20110262897 Imaging techniques using a tridentate ligand
10/27/2011	US20110262894 Vaccine against infectious agents having an intracellular phase, composition for the treatment and prevention of hiv infections, antibodies and methods of diagnosis
10/27/2011	US20110262508 Antimicrobial compositions, formulations and uses thereof
10/27/2011	US20110262488 Novel HIV-1 Envelope Glycoprotein
10/27/2011	US20110262485 Sting (stimulator of interferon genes), a regulator of innate immune responses
10/27/2011	US20110262479 Recombinant mhc molecules useful for manipulation of antigen-specific t-cells
10/27/2011	US20110262476 Mutant bacterial glycoproteins and uses thereof
10/27/2011	US20110262475 Lyme disease vaccine
10/27/2011	US20110262474 Chimeric HIV Antigens
10/27/2011	US20110262471 Rab6kifl/kif20a epitope peptide and vaccines containing the same
10/27/2011	US20110262469 Malaria vaccine based on fragments and combination of fragments of the cs protein of plasmodium vivax
10/27/2011	US20110262443 Epitopes Of Il-17a And Il-17f And Antibodies Specific Thereto
10/27/2011	US20110262432 mutated netrin 4 proteins, fragments thereof and their uses as drugs
10/27/2011	US20110262414 High affinity ny-eso t cell receptors
10/27/2011	US20110262411 Bacteriophage derived methods to control lactic acid bacterial growth
10/27/2011	US20110262394 Dna constructs eliciting immune response against flavivirus and effective adjuvants
10/27/2011	US20110262393 Composition comprising mesenchymal stem cells or culture solution of mesenchymal stem cells for the prevention or treatment of neural diseases
10/27/2011	US20110262390 Composition and method for treating inflammatory disorders
10/27/2011	US20110262366 Compounds for targeting endothelial cells, compositions containing the same and methods for their use
10/27/2011	US20110262353 Muteins of hngal and related proteins with affinity for a given target
10/27/2011	US20110262347 Methods and compositions for enhanced delivery of compounds
10/27/2011	US20110260584 Piezoelectric polymer fibers
10/27/2011	US20110259830 Seed-conjugated polymer support
10/27/2011	CA2834001A1 Method for the identification of t cell epitopes
10/27/2011	CA2800343A1 Process for the production of cells which are capable of converting arabinose
10/27/2011	CA2796758A1 Combinations including cry3aa and cry6aa proteins to prevent development of resistance in corn rootworms (diabrotica spp.)
10/27/2011	CA2796730A1 Combinations including cry34ab/35ab and cry3ba proteins to prevent development of resistance in corn rootworms (diabrotica spp.)
10/27/2011	CA2796729A1 New stabilizing agent for pharmaceutical proteins
10/27/2011	CA2796727A1 Combinations including cry34ab/35ab and cry3aa proteins to prevent development of resistance in corn rootworms (diabrotica spp.)
10/27/2011	CA2794817A1 Cell suitable for fermentation of a mixed sugar composition
10/27/2011	CA2794556A1 Novel allergen
10/27/2011	CA2791158A1 Methods for tissue decellularization
10/26/2011	EP2381256A1 Mammalian sweet and amino acid heterodimeric taste receptors
10/26/2011	EP2381254A1 Copolymer assay
10/26/2011	EP2380986A1 Use of stomatin (STM1) polynucleotides for achieving a pathogen resistance in plants
10/26/2011	EP2380983A2 RAGE fusion proteins, formulations, and methods of use thereof
10/26/2011	EP2380982A1 Orthogonal translation components for the in vivo incorporation of unnatural amino acids
10/26/2011	EP2380979A1 Protein substance having triple helix structure and manufacturing method therefor
10/26/2011	EP2380914A1 Fusion proteins of apoptin-protein transduction domain of carboxyl-terminal end of ec-sod
10/26/2011	EP2380906A2 Artificial antibody polypeptides
10/26/2011	EP2380905A1 Phospholipid-enriched vesicles bearing tissue factor having haemostatic activities and uses thereof
10/26/2011	EP2380904A1 G protein coupled receptor agonists and antagonists and methods of use
10/26/2011	EP2380903A1 Differential in tumour gene products and use of same
10/26/2011	EP2380902A1 Protein layers and their use in X-ray crystallography
10/26/2011	EP2380900A1 Isolation and use of ryanodine receptors
10/26/2011	EP2380899A1 Isolation and use of ryanodine receptors
10/26/2011	EP2380633A1 Use of IL-21 in cancer
10/26/2011	EP2380590A2 Improved tuberculosis vaccines
10/26/2011	EP2380589A2 Improved tuberculosis vaccines
10/26/2011	EP2380435A2 Feline-derived protein and method for production thereof
10/26/2011	EP2379724A2 Axmi-150 delta-endotoxin gene and methods for its use
10/26/2011	EP2379723A1 Bidirectional promoter from z. mais
10/26/2011	EP2379598A1 Anti-kir3d antibodies
10/26/2011	EP2379594A1 Human cgrp receptor binding proteins
10/26/2011	EP2379589A2 Compounds, compositions and use
10/26/2011	EP2379588A2 The use of basigin-1 in stem cell and cancer applications
10/26/2011	EP2379587A1 Melanocortin analogs with antimicrobial activity
10/26/2011	EP2379586A1 Oncolytic adenoviral vectors and methods and uses related thereto
10/26/2011	EP2379585A2 Polypeptides that bind trail-ri and trail-r2
10/26/2011	EP2379584A1 Soluble polypeptides for use in treating autoimmune and inflammatory disorders
10/26/2011	EP2379583A1 Modular dna-binding domains and methods of use
10/26/2011	EP2379582A1 Plants having enhanced yield-related traits and/or abiotic stress tolerance and a method for making the same
10/26/2011	EP2379581A2 A method for identifying hetero-multimeric modified ubiquitin proteins with binding capability to ligands
10/26/2011	EP2379577A1 Compositions and methods for re-programming cells without genetic modification
10/26/2011	EP2379107A1 Ljungan virus with improved replication characteristics
10/26/2011	EP2379106A1 Chlamydia antigens and uses thereof
10/26/2011	EP2379101A1 Mutated antithrombins, a process for preparing the same and their use as drugs
10/26/2011	EP2379098A1 Compositions and methods to prevent cancer with cupredoxins
10/26/2011	EP2379097A1 Compositions and methods to prevent cancer with cupredoxins
10/26/2011	EP2379053A1 Prophylactic/therapeutic agent for cancer
10/26/2011	EP2378875A1 Cell-permeant peptide-based inhibitor of kinases
10/26/2011	EP2193200B1 Nucleic acid codifying for a utrophin transcription specific regulating protein, protein codified thereby and uses thereof
10/26/2011	EP2183280B1 Collagen-related peptides and uses thereof
10/26/2011	EP2150561B1 Demannosylated recombinant factor VIII for the treatment of patients with haemophilia A
10/26/2011	EP2118125B1 Peptide-complement conjugates
10/26/2011	EP2092335B1 A homogeneous time resolved fluorescence based test system for paramyxoviridae

1 ... 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 ... 2916